{"nct_id":"NCT05081609","title":"A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2022-01-11","start_date_type":"ACTUAL","primary_completion_date":"2027-08","primary_completion_date_type":"ESTIMATED","completion_date":"2029-08","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ASND"]}